StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 612 participants.

Also called NCT06785727

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 612 participants (planned count) (from the registry)
Sponsor
Prof. dr. Nathalie van der Velde (from the registry)
Registry
  • NCT NCT06785727
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06785727. Randomized; single masking; primary purpose prevention. Start 2025-02-01 (anticipated); primary completion 2028-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial
Acronym
SAFEST - RCT
Intervention (Drug)
Statin (atorvastatin, fluvastatin, pravastatin, rosuvastatin or simvastatin)
Lead sponsor
Prof. dr. Nathalie van der Velde (class: other)
Collaborator
VU University of Amsterdam (class: other)

Record details

Record id
cardio:ct-nct06785727
Content hash
5eba1b541d58be1cab924eadf5cd26e540ba36f79e3903de1b519a6778c58eb6